MedTrace Logo

Safety and Efficacy of SDX-3101 for the Treatment of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)

NCT04158596 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-10-22

No results posted yet for this study

Summary

The purpose of this clinical trial is to assess the safety and efficacy of SDX-3101 for treatment of adult patients with chronic rhinosinusitis without nasal polyps (CRSsNP) by investigating a vibration pattern of SDX-3101 compared to a control

Conditions

  • Chronic Rhinosinusitis Without Nasal Polyps

Interventions

DEVICE

Vibration Therapy

SDX-3101 is used for drug-free treatment of CRSsNP in adults.

Sponsors & Collaborators

  • ISS AG

    collaborator UNKNOWN

  • SynDermix AG

    lead INDUSTRY

Principal Investigators

  • Carlos R Camozzi, MD · SynDermix AG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-10-31
Completion
2021-10-31

Countries

  • Austria
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04158596 on ClinicalTrials.gov